Posted: August 2018
Avrum Spira, MD, has been named global head of the new Lung Cancer Initiative within Johnson & Johnson, which will be based at Boston University’s Medical Campus. This initiative is a 5-year research alliance with Johnson & Johnson Innovation LLC; it aims to develop biomarker-based early-screening tests for lung cancer. Dr. Spira is a School of Medicine professor of medicine, pathology, and bioinformatics, and is leading two separate ongoing research projects through the new initiative: Detection of Early Cancer Among Military Personnel (DECAMP) and the development of a precancer genome atlas to characterize molecular changes that lead to invasive lung cancer.
